Skip to main content

Research Repository

Advanced Search

Dr FIONA PEARCE's Outputs (13)

Key features of effective yoga interventions in addition to standard medical treatment for rheumatoid arthritis: a systematic review and meta-analysis (2025)
Journal Article
Biswas, I., Kaur, J., Pearce, F., Lewis, S., & Chattopadhyay, K. (2025). Key features of effective yoga interventions in addition to standard medical treatment for rheumatoid arthritis: a systematic review and meta-analysis. ACR Open Rheumatology, 7(5), Article e70054. https://doi.org/10.1002/acr2.70054

Objective: This systematic review aimed to synthesise the content, structure, and delivery characteristics of effective yoga interventions in addition to standard medical treatment for rheumatoid arthritis (RA).

Methods: JBI guidelines were follow... Read More about Key features of effective yoga interventions in addition to standard medical treatment for rheumatoid arthritis: a systematic review and meta-analysis.

Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases (2025)
Journal Article
Lax, S. J., Dures, E., Bridgewater, S., Silverthorne, C. A., Lowndes, V., Richards, P., Ferreira, A., Shepherd, M. A., Dawson, J., Hill, C., Goodman, S., Mackie, S. L., Ndosi, M., Pearce, F. A., & Robson, J. C. (2025). Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases. Rheumatology, https://doi.org/10.1093/rheumatology/keaf121

Objective

To explore patients’ perspectives on the impact of appearance changes attributed to glucocorticoid treatment.

Methods

A secondary inductive thematic analysis was conducted of the ‘Steroid PRO’ semi-structured interviews with patien... Read More about Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases.

Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study (2025)
Journal Article
Mumford, L., Hogg, R., Taylor, A., Lanyon, P., Bythell, M., McPhail, S., Chilcot, J., Powter, G., Cooke, G. S., Ward, H., Thomas, H., McAdoo, S. P., Lightstone, L., Lim, S. H., Pettigrew, G. J., Pearce, F. A., & Willicombe, M. (2025). Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study. Lancet, 405(10475), 314-328. https://doi.org/10.1016/S0140-6736%2824%2902560-1

Background: In the UK, booster COVID-19 vaccinations have been recommended biannually to people considered immune vulnerable. We investigated, at a population level, whether the absence of detectable anti-SARS-CoV-2 spike protein IgG antibody (anti-S... Read More about Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study.

A meta-analysis and systematic review of the use of transition tools for patients transitioning from paediatric to adult rheumatology services (2024)
Journal Article
Griffin, K., Pearce, F., & Packham, J. (2024). A meta-analysis and systematic review of the use of transition tools for patients transitioning from paediatric to adult rheumatology services. Rheumatology Advances in Practice, 8(4), Article rkae130. https://doi.org/10.1093/rap/rkae130

Introduction: Transition from paediatric to adult care can be challenging, but transition tools are designed to increase successful rates of transfer.
Objectives: Conduct a meta-analysis and systematic review into the use of transition tools on tran... Read More about A meta-analysis and systematic review of the use of transition tools for patients transitioning from paediatric to adult rheumatology services.

Prevalence, Incidence, and Mortality of Raynaud’s phenomenon, Sjögren’s syndrome, and scleroderma: an umbrella review of systematic reviews (2024)
Journal Article
Chen, A., Lax, S. J., Grainge, M. J., Lanyon, P. C., & Pearce, F. A. (2024). Prevalence, Incidence, and Mortality of Raynaud’s phenomenon, Sjögren’s syndrome, and scleroderma: an umbrella review of systematic reviews. Rheumatology Advances in Practice, 8(3), Article rkae086. https://doi.org/10.1093/rap/rkae086

Objectives:

To comprehensively review systematic reviews of prevalence, incidence, and mortality of Raynaud’s, Sjögren’s, and Scleroderma, and to identify any research gaps.

Methods:

An umbrella review of English language systematic review... Read More about Prevalence, Incidence, and Mortality of Raynaud’s phenomenon, Sjögren’s syndrome, and scleroderma: an umbrella review of systematic reviews.

Antibody response to four doses of SARS-CoV-2 vaccine in rare autoimmune rheumatic diseases: an observational study (2023)
Journal Article
Gumber, L., Jackson, H., Gomez, N., Hopkins, G., Tucis, D., Chakravorty, M., Tighe, P., Grainge, M. J., Rutter, M., Ferraro, A., Power, S., Pradère, M.-J., Lanyon, P. C., Pearce, F. A., & Fairclough, L. (2023). Antibody response to four doses of SARS-CoV-2 vaccine in rare autoimmune rheumatic diseases: an observational study. Rheumatology Advances in Practice, 7(3), Article rkad097. https://doi.org/10.1093/rap/rkad097

Objective: Antibody responses to coronavirus disease 2019 (COVID-19) vaccines are reduced among immunocompromised patients but are not well quantified among people with rare disease. We conducted an observational study to evaluate the antibody respon... Read More about Antibody response to four doses of SARS-CoV-2 vaccine in rare autoimmune rheumatic diseases: an observational study.

Long-term outcomes (beyond 5 years) of liver transplant recipients - a transatlantic multicentre study (2023)
Journal Article
Palaniyappan, N., Peach, E., Pearce, F., Dhaliwal, A., Campos-Varela, I., Cant, M. R., Dopazo, C., Trotter, J., Divani-Patel, S., AZ Hatta, A., Hopkins, L., Testa, G., Bilbao, A., Kasmani, Z., Faloon, S., Mirza, D. F., Klintmalm, G. B., Bilbao, I., Asrani, S. K., Rajoriya, N., & Aravinthan, A. D. (2024). Long-term outcomes (beyond 5 years) of liver transplant recipients - a transatlantic multicentre study. Liver Transplantation, 30(2), 170-181. https://doi.org/10.1097/LVT.0000000000000244

The long-term (>5 year) outcomes following liver transplantation (LT) have not been extensively reported. The aim was to evaluate outcomes of LT recipients who have survived the first 5 years. A
multicentre retrospective analysis of prospectively... Read More about Long-term outcomes (beyond 5 years) of liver transplant recipients - a transatlantic multicentre study.

Long-term outcomes (beyond 5 years) of liver transplant recipients--a transatlantic multicenter study (2023)
Journal Article
Palaniyappan, N., Peach, E., Pearce, F., Dhaliwal, A., Campos-Varela, I., Cant, M. R., Dopazo, C., Trotter, J., Divani-Patel, S., Hatta, A. A., Hopkins, L., Testa, G., Bilbao, A., Kasmani, Z., Faloon, S., Mirza, D. F., Klintmalm, G. B., Bilbao, I., Asrani, S. K., Rajoriya, N., & Aravinthan, A. D. (2024). Long-term outcomes (beyond 5 years) of liver transplant recipients--a transatlantic multicenter study. Liver Transplantation, 30(2), 170-181. https://doi.org/10.1097/LVT.0000000000000244

The long-term (>5y) outcomes following liver transplantation (LT) have not been extensively reported. The aim was to evaluate outcomes of LT recipients who have survived the first 5 years. A multicenter retrospective analysis of prospectively collect... Read More about Long-term outcomes (beyond 5 years) of liver transplant recipients--a transatlantic multicenter study.

Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY (2023)
Journal Article
Pearce, F. A., Lim, S. H., Bythell, M., Lanyon, P., Hogg, R., Taylor, A., Powter, G., Cooke, G. S., Ward, H., Chilcot, J., Thomas, H., Mumford, L., McAdoo, S. P., Pettigrew, G. J., Lightstone, L., & Willicombe, M. (2023). Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY. The Lancet Rheumatology, 5(8), E461-E473. https://doi.org/10.1016/S2665-9913%2823%2900160-1

Background:
In the UK, additional COVID-19 vaccine booster doses and treatments are offered to people who are immunosuppressed to protect against severe COVID-19, but how best to choose the individuals that receive these vaccine booster doses and t... Read More about Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY.

COVID-19 infection, admission and death and the impact of corticosteroids amongst people with rare autoimmune rheumatic disease during the second wave of covid-19 in England: results from the RECORDER Project (2023)
Journal Article
Rutter, M., Lanyon, P. C., Grainge, M. J., Hubbard, R., Bythell, M., Stilwell, P., Aston, J., McPhail, S., Stevens, S., & Pearce, F. A. (2023). COVID-19 infection, admission and death and the impact of corticosteroids amongst people with rare autoimmune rheumatic disease during the second wave of covid-19 in England: results from the RECORDER Project. Rheumatology, 62(12), 3828-3837. https://doi.org/10.1093/rheumatology/kead150

Objectives
To calculate the rates of COVID-19 infection and COVID-19-related death among people with rare autoimmune rheumatic diseases (RAIRD) during the second wave of the COVID-19 pandemic in England, and describe the impact of corticosteroids on... Read More about COVID-19 infection, admission and death and the impact of corticosteroids amongst people with rare autoimmune rheumatic disease during the second wave of covid-19 in England: results from the RECORDER Project.

The incidence of Kawasaki disease using hospital admissions data for England 2006-2021 (2023)
Journal Article
Odingo, M., Rutter, M., Bowley, J., Peach, E. J., Lanyon, P. C., Grainge, M. J., Stillwell, P., McPhail, S., Bythell, M., Aston, J., Stevens, S., McCormack, R., Brogan, P., & Pearce, F. A. (2023). The incidence of Kawasaki disease using hospital admissions data for England 2006-2021. Rheumatology, 62(9), 3117–3125. https://doi.org/10.1093/rheumatology/kead051

Objective: To describe the incidence of Kawasaki Disease (kDa) between 2006 and 2021 in England. Methods: We identified all cases in hospital episode statistics with an ICD-10 diagnostic code M303 (for kDa) between 1 April 2006 and 31 March 2021. We... Read More about The incidence of Kawasaki disease using hospital admissions data for England 2006-2021.

Validation of methods to identify people with idiopathic inflammatory myopathies using hospital episode statistics (2022)
Journal Article
Hannah, J., Gordon, P., Galloway, J., Rutter, M., Peach, E., Rooney, M., Stilwell, P., Grainge, M., Lanyon, P., Bythell, M., & Pearce, F. (2022). Validation of methods to identify people with idiopathic inflammatory myopathies using hospital episode statistics. Rheumatology Advances in Practice, 6(3), Article rkac102. https://doi.org/10.1093/rap/rkac102

Objective: Hospital episode statistics (HES) are routinely recorded at every hospital admission within the National Health Service (NHS) in England. This study validates diagnostic ICD-10 codes within HES as a method of identifying cases of idiopathi... Read More about Validation of methods to identify people with idiopathic inflammatory myopathies using hospital episode statistics.